Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
AstraZeneca PLC First Quarter Results 2011
-
FDA approves orphan drug vandetanib
-
UK and US governments reach agreement over AstraZeneca tax matters
-
AstraZeneca initiates phase III clinical programme evaluating NKTR-118 for treatment of opioid-induced constipation
-
FDA accepts new drug application for investigational compound Dapagliflozin for the treatment of type 2 diabetes
-
AstraZeneca to discontinue production of PULMICORT® pMDI, other respiratory medicines not affected
-
Onglyza becomes the first DPP4 inhibitor available for use in Europe in Type 2 Diabetes patients with moderate or severe renal impairment
-
ONGLYZA™ US label update provides further evidence regarding use in renally impaired adults with type 2 diabetes
-
AstraZeneca and Targacept initiate phase IIB clinical trial of TC-5214 as a switch monotherapy treatment for major depressive disorder
-
AstraZeneca halts phase III trial of ZIBOTENTAN in non-metastatic castrate resistant prostate cancer
Latest articles and press releases
All of our latest press releases and articles are available to explore
